The economic burden of systemic lupus erythematosus in Taiwan

References

• Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J Rare Dis. 2006;1(1):6. doi: 10.1186/1750-1172-1-6.
   PubMed Web of Science ®Google Scholar
• Ameer MA, Chaudhry H, Mushtaq J, et al. An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus. 2022;14(10):e30330. doi: 10.7759/cureus.30330.
   PubMed Web of Science ®Google Scholar
• Kuhn A, Bonsmann G, Anders HJ, et al. The diagnosis and treatment of systemic lupus erythematosus. Dtsch Arztebl Int. 2015;112(25):423–432. doi: 10.3238/arztebl.2015.0423.
   PubMed Web of Science ®Google Scholar
• Castro-Villarreal S, Beltran-Ostos A, Valencia CF. Estimation of prevalence and incremental costs of systemic lupus erythematosus in a middle-income country using machine learning on administrative health data. Value Health Reg Issues. 2021;26:98–104. doi: 10.1016/j.vhri.2021.04.005.
   PubMedGoogle Scholar
• Yen EY, Singh RR. Brief report: lupus-an unrecognized leading cause of death in young females: a population-based study using nationwide death certificates, 2000-2015. Arthritis Rheumatol. 2018;70(8):1251–1255. doi: 10.1002/art.40512.
   PubMed Web of Science ®Google Scholar
• Tian J, Zhang D, Yao X, et al. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023;82(3):351–356. doi: 10.1136/ard-2022-223035.
   PubMed Web of Science ®Google Scholar
• See LC, Kuo CF, Chou IJ, et al. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum. 2013;43(3):381–386. doi: 10.1016/j.semarthrit.2013.06.001.
   PubMed Web of Science ®Google Scholar
• Yeh KW, Yu CH, Chan PC, et al. Burden of systemic lupus erythematosus in Taiwan: a population-based survey. Rheumatol Int. 2013;33(7):1805–1811. doi: 10.1007/s00296-012-2643-6.
   PubMed Web of Science ®Google Scholar
• Jolly M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol. 2005;32(9):1706–1708.
   PubMed Web of Science ®Google Scholar
• Pettersson S, Lövgren M, Eriksson LE, et al. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scand J Rheumatol. 2012;41(5):383–390. doi: 10.3109/03009742.2012.677857.
   PubMed Web of Science ®Google Scholar
• Meszaros ZS, Perl A, Faraone SV. Psychiatric symptoms in systemic lupus erythematosus: a systematic review. J Clin Psychiatry. 2012;73(7):993–1001. doi: 10.4088/JCP.11r07425.
   PubMed Web of Science ®Google Scholar
• Durcan L, O’Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393(10188):2332–2343. doi: 10.1016/S0140-6736(19)30237-5.
   PubMed Web of Science ®Google Scholar
• Felten R, Sagez F, Gavand PE, et al. 10 Most important contemporary challenges in the management of SLE. Lupus Sci Med. 2019;6(1):e000303. doi: 10.1136/lupus-2018-000303.
   PubMed Web of Science ®Google Scholar
• Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(2):144–150. doi: 10.1097/BOR.0000000000000480.
   PubMed Web of Science ®Google Scholar
• Lee YH, Choi SJ, Ji JD, et al. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus. 2016;25(7):727–734. doi: 10.1177/0961203315627202.
   PubMed Web of Science ®Google Scholar
• Ruperto N, Hanrahan LM, Alarcón GS, et al. International consensus for a definition of disease flare in lupus. Lupus. 2011;20(5):453–462. doi: 10.1177/0961203310388445.
   PubMed Web of Science ®Google Scholar
• Ugarte-Gil MF, Gamboa-Cardenas RV, Reátegui-Sokolova C, et al. Severe flares are associated with a poorer health-related quality of life (HRQoL) in patients with SLE: data from the Almenara Lupus Cohort. Lupus Sci Med. 2022;9(1):e000641. doi: 10.1136/lupus-2021-000641.
   PubMed Web of Science ®Google Scholar
• Adamichou C, Bertsias G. Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies. Mediterr J Rheumatol. 2017;28(1):4–12. doi: 10.31138/mjr.28.1.4.
   PubMedGoogle Scholar
• Tanaka Y, Mizukami A, Kobayashi A, et al. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: a retrospective, observational study. Int J Rheum Dis. 2018;21(8):1609–1618. doi: 10.1111/1756-185X.13363.
   PubMed Web of Science ®Google Scholar
• Murimi-Worstell IB, Lin DH, Nab H, et al. Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis. BMJ Open. 2020;10(5):e031850. doi: 10.1136/bmjopen-2019-031850.
   PubMed Web of Science ®Google Scholar
• Sheane BJ, Gladman DD, Su J, et al. Disease outcomes in glucocorticosteroid-Naive patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2017;69(2):252–256. doi: 10.1002/acr.22938.
   PubMed Web of Science ®Google Scholar
• Chambers SA, Allen E, Rahman A, et al. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford). 2009;48(6):673–675. doi: 10.1093/rheumatology/kep062.
   PubMed Web of Science ®Google Scholar
• Arnaud L, Tektonidou MG. Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology (Oxford). 2020;59(Suppl5):v29–v38. doi: 10.1093/rheumatology/keaa382.
   PubMedGoogle Scholar
• Tamirou F, Arnaud L, Talarico R, et al. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018;4(2):e000793. doi: 10.1136/rmdopen-2018-000793.
   PubMedGoogle Scholar
• Maroz N, Segal MS. Lupus nephritis and end-stage kidney disease. Am J Med Sci. 2013;346(4):319–323. doi: 10.1097/MAJ.0b013e31827f4ee3.
   PubMed Web of Science ®Google Scholar
• Bell CF, Ajmera MR, Meyers J. An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States. Lupus. 2022;31(2):202–211. doi: 10.1177/09612033211073670.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Hussain F, Ibañez D, et al. The nature and outcome of infection in systemic lupus erythematosus. Lupus. 2002;11(4):234–239. doi: 10.1191/0961203302lu170oa.
   PubMed Web of Science ®Google Scholar
• Tektonidou MG, Wang Z, Dasgupta A, et al. Burden of serious infections in adults with systemic lupus erythematosus: a national population-based study, 1996-2011. Arthritis Care Res (Hoboken). 2015;67(8):1078–1085. doi: 10.1002/acr.22575.
   PubMed Web of Science ®Google Scholar
• Tektonidou MG, Lewandowski LB, Hu J, et al. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis. 2017;76(12):2009–2016. doi: 10.1136/annrheumdis-2017-211663.
   PubMed Web of Science ®Google Scholar
• Isenberg DA, Rahman A, Allen E, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group’s disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005;44(7):902–906. doi: 10.1093/rheumatology/keh624.
   PubMed Web of Science ®Google Scholar
• The world factbook, age structure, Taiwan. 2023 Jul. https://www.cia.gov/the-world-factbook/field/age-structure/
   Google Scholar
• Chang YS, Huang WN, Tang CH, et al. Ab0428 treatment patterns of systemic lupus erythematosus patients in Taiwan – a population-based analysis. Ann Rheum Dis. 2022;81(Suppl 1):1342–1342. doi: 10.1136/annrheumdis-2022-eular.1850.
   Google Scholar
• Nikolopoulos DS, Kostopoulou M, Pieta A, et al. Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease. Lupus Sci Med. 2020;7(1):e000394. doi: 10.1136/lupus-2020-000394.
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)–explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013;16(2):231–250. doi: 10.1016/j.jval.2013.02.002.
   PubMed Web of Science ®Google Scholar
• Caro JJ, Briggs AH, Siebert U, et al. Modeling good research practices–overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Med Decis Making. 2012;32(5):667–677. doi: 10.1177/0272989X12454577.
   PubMed Web of Science ®Google Scholar
• Hung MC, Lai WW, Chen HH, et al. Cost effectiveness of cancer treatment in Taiwan. J Formos Med Assoc. 2016;115(8):609–618. doi: 10.1016/j.jfma.2016.04.002.
   PubMed Web of Science ®Google Scholar
• Liu PH, Hu FC, Lee PI, et al. Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan. BMC Health Serv Res. 2010;10(1):11. doi: 10.1186/1472-6963-10-11.
   PubMedGoogle Scholar
• Zhang Y, Li W, Zhang P, et al. Hematological malignancies in systemic lupus erythematosus: clinical characteristics, risk factors, and prognosis—a case-control study. Arthritis Res Ther. 2022;24(1):5. doi: 10.1186/s13075-021-02692-8.
   PubMed Web of Science ®Google Scholar
• Giannouli S, Voulgarelis M, Ziakas PD, et al. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis. 2006;65(2):144–148. doi: 10.1136/ard.2005.041673.
   PubMed Web of Science ®Google Scholar
• Lu MC, Hsu CW, Lo HC, et al. Association of clinical manifestations of systemic lupus erythematosus and complementary therapy use in Taiwanese female patients: a cross-sectional study. Medicina (Kaunas). 2022;58(7):944. doi: 10.3390/medicina58070944.
   PubMed Web of Science ®Google Scholar
• Amaya-Amaya J, Sarmiento-Monroy JC, Caro-Moreno J, et al. Cardiovascular disease in Latin American patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. Autoimmune Dis. 2013;2013:794383. doi: 10.1155/2013/794383.
   PubMedGoogle Scholar
• Jakes RW, Bae SC, Louthrenoo W, et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken). 2012;64(2):159–168. doi: 10.1002/acr.20683.
   PubMed Web of Science ®Google Scholar
• Tektonidou MG, Dasgupta A, Ward MM. Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol. 2016;68(6):1432–1441. doi: 10.1002/art.39594.
   PubMed Web of Science ®Google Scholar
• Wu MJ, Lo YC, Lan JL, et al. Outcome of lupus nephritis after entering into end-stage renal disease and comparison between different treatment modalities: a nationwide population-based cohort study in Taiwan. Transplant Proc. 2014;46(2):339–341. doi: 10.1016/j.transproceed.2013.11.080.
   PubMed Web of Science ®Google Scholar
• Hammond ER, Desta B, Near AM, et al. Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004-2015. Lupus Sci Med. 2021;8(1):e000504. doi: 10.1136/lupus-2021-000504.
   PubMed Web of Science ®Google Scholar
• Ko T, Koelmeyer R, Li N, et al. Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysis. Semin Arthritis Rheum. 2022;57:152099. doi: 10.1016/j.semarthrit.2022.152099.
   PubMed Web of Science ®Google Scholar
• National Statistics, Republic of China (Taiwan). Labor force participation rate. 2023 Jul. Available from: https://manpower.dgbas.gov.tw/dgbas_community/Common_Inquire/SearchResult_eng?type=LFP
   Google Scholar
• Drenkard C, Bao G, Dennis G, et al. Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States. Arthritis Care Res (Hoboken). 2014;66(6):878–887. doi: 10.1002/acr.22245.
   PubMed Web of Science ®Google Scholar
• Utset TO, Baskaran A, Segal BM, et al. Work disability, lost productivity and associated risk factors in patients diagnosed with systemic lupus erythematosus. Lupus Sci Med. 2015;2(1):e000058. doi: 10.1136/lupus-2014-000058.
   PubMedGoogle Scholar
• National Statistics in Taiwan. Gross domestic product. 2023 Jul. from:https://eng.stat.gov.tw/Point.aspx?sid=t.1&n=4200&sms=11713
   Google Scholar
• Moroni G, Frontini G, Ponticelli C. When and how is it possible to stop therapy in patients with lupus nephritis: a narrative review. Clin J Am Soc Nephrol. 2021;16(12):1909–1917. doi: 10.2215/CJN.04830421.
   PubMed Web of Science ®Google Scholar
• Amissah-Arthur MB, Gordon C. Contemporary treatment of systemic lupus erythematosus: an update for clinicians. Ther Adv Chronic Dis. 2010;1(4):163–175. doi: 10.1177/2040622310380100.
   PubMedGoogle Scholar
• Karim MY, Alba P, Cuadrado MJ, et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford). 2002;41(8):876–882. doi: 10.1093/rheumatology/41.8.876.
   PubMed Web of Science ®Google Scholar
• Porta S, Danza A, Arias Saavedra M, et al. Glucocorticoids in systemic lupus erythematosus. Ten questions and some issues. J Clin Med. 2020;9(9):2709. doi: 10.3390/jcm9092709.
   PubMed Web of Science ®Google Scholar
• Kernder A, Richter JG, Fischer-Betz R, et al. Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: cross sectional analysis of the LuLa cohort. Lupus. 2021;30(3):431–438. doi: 10.1177/0961203320983445.
   PubMed Web of Science ®Google Scholar
• Emery P, Zeidler H, Kvien TK, et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet. 1999;354(9196):2106–2111. doi: 10.1016/S0140-6736(99)02332-6.
   PubMed Web of Science ®Google Scholar
• Chen ASH, Lee JH, Ya-Chiao H, et al. AB0974 analysis of dyslipidemia in systemic lupus erythematosus. Ann Rheum Dis. 2020;79(Suppl 1):1782. doi: 10.1136/annrheumdis-2020-eular.5742.
   Google Scholar
• Hannah JR, D’Cruz DP. Pulmonary complications of systemic lupus erythematosus. Semin Respir Crit Care Med. 2019;40(2):227–234. doi: 10.1055/s-0039-1685537.
   PubMed Web of Science ®Google Scholar
• Cojocaru M, Cojocaru IM, Silosi I, et al. Manifestations of systemic lupus erythematosus. Maedica. 2011;6(4):330–336.
   PubMedGoogle Scholar
• Narváez J, Ricse M, Gomà M, et al. The value of repeat biopsy in lupus nephritis flares. Medicine (Baltimore). 2017;96(24):e7099. doi: 10.1097/MD.0000000000007099.
   PubMed Web of Science ®Google Scholar
• Anders HJ, Saxena R, Zhao M, et al. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):7. doi: 10.1038/s41572-019-0141-9.
   PubMed Web of Science ®Google Scholar
• Aghdassi E, Zhang W, St-Pierre Y, et al. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis. J Rheumatol. 2011;38(4):658–666. doi: 10.3899/jrheum.100482.
   PubMed Web of Science ®Google Scholar
• Lin DH, Murimi-Worstell IB, Kan H, et al. Health care utilization and costs of systemic lupus erythematosus in the United States: a systematic review. Lupus. 2022;31(7):773–807. doi: 10.1177/09612033221088209.
   PubMed Web of Science ®Google Scholar
• Katz P, Nelson WW, Daly RP, et al. Patient-reported lupus flare symptoms are associated with worsened patient outcomes and increased economic burden. J Manag Care Spec Pharm. 2020;26(3):275–283. doi: 10.18553/jmcp.2020.26.3.275.
   PubMed Web of Science ®Google Scholar
• Wu TY, Majeed A, Kuo KN. An overview of the healthcare system in Taiwan. London J Prim Care (Abingdon). 2010;3(2):115–119. doi: 10.1080/17571472.2010.11493315.
   PubMedGoogle Scholar
• Gusmano MK. Taiwan: achievements and challenges in a single-payer system. In: Palley HA, editor, The public/private sector mix in healthcare delivery: a comparative study. Online ed. New York (NY): Oxford Academic; 2023. doi: 10.1093/oso/9780197571101.003.0013.
   Google Scholar
• Miyazaki C, Sruamsiri R, Mahlich J, et al. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study. J Med Econ. 2020;23(7):786–799. doi: 10.1080/13696998.2020.1740236.
   PubMed Web of Science ®Google Scholar
• Utset TO, Chohan S, Booth SA, et al. Correlates of formal work disability in an urban university systemic lupus erythematosus practice. J Rheumatol. 2008;35(6):1046–1052.
   PubMed Web of Science ®Google Scholar